Literature DB >> 11746040

Syndrome of coronal craniosynostosis, Klippel-Feil anomaly, and sprengel shoulder with and without Pro250Arg mutation in the FGFR3 gene.

R B Lowry1, E W Jabs, G E Graham, J Gerritsen, J Fleming.   

Abstract

A unique Pro250Arg point mutation in fibroblast growth factor receptor 3 (FGFR3) was initially reported by Bellus et al. [1996: Nat Genet 14:174-176] and the phenotype subsequently by Muenke et al. [1997: Am J Hum Genet 60:555-564], Reardon et al. [1997: J Med Genet 34:632-636], and Graham et al. [1998: Am J Med Genet 77:322-329]. These authors emphasized the pleiotropic nature of this form of coronal craniosynostosis, including brachydactyly with carpal and/or tarsal coalitions, with other anomalies at lower frequency. We report on a family with autosomal dominant coronal synostosis, segmentation and fusion anomalies of the vertebra and ribs, and Sprengel shoulder due to the Pro250Arg mutation. We also report a single case with an identical phenotype without the mutation. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746040     DOI: 10.1002/ajmg.10049

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

1.  Muenke syndrome: Medical and surgical comorbidities and long-term management.

Authors:  Chaya N Murali; Donna M McDonald-McGinn; Tara Lynn Wenger; Carey McDougall; Bridget M Stroup; Sarah E Sheppard; Jesse Taylor; Scott P Bartlett; Elizabeth J Bhoj; Elaine H Zackai; Avni Santani
Journal:  Am J Med Genet A       Date:  2019-05-20       Impact factor: 2.802

2.  Identification of differentially expressed genes in early inner ear development.

Authors:  Christian N Paxton; Steven B Bleyl; Susan C Chapman; Gary C Schoenwolf
Journal:  Gene Expr Patterns       Date:  2009-11-11       Impact factor: 1.224

3.  Hearing loss in a mouse model of Muenke syndrome.

Authors:  Suzanne L Mansour; Stephen R F Twigg; Rowena M Freeland; Steven A Wall; Chaoying Li; Andrew O M Wilkie
Journal:  Hum Mol Genet       Date:  2008-09-25       Impact factor: 6.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.